Follow The Filings

MHK Mohawk Industries Inc.

Consumer Discretionary, filed as MOHAWK INDS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 1

  • 4 Owners
  • Max 2.4%
  • $450M
  • 1 new 1 exit 3 small

In 2026 Q2 Ron Baron opened a position in Mohawk Industries, while Alex Roepers sold out.

Who owns this now

Largest portfolio weights among holders, up to 2.4% (Harry Burn, Sound Shore Management). Not free-float ownership.

  1. Harry Burn Reduce 2.4%
  2. John Rogers Add 2.1%
  3. Richard Pzena Reduce 0.41%
  4. Ron Baron New 0.03%

Who owns MHK

Sorted by value, long equity only, as of 2026 Q2.

History
John Rogers, Ariel Investments 2.1%, was 1.9% Small add +0.7% 1,756,773 $213M History
Richard Pzena, Pzena Investment Management 0.41% Small trim −0.9% 1,142,841 $139M History
Harry Burn, Sound Shore Management 2.4% Small trim −1.3% 634,336 $77M History
Ron Baron, Bamco Inc. (Baron Capital) 0.03% New 0.03% 171,703 $21M History
Alex Roepers, Atlantic Investment Management exited 2026 Q2 Last 2026 Q1 2.3% Exit −2.29% 40,000 $3.9M History

4 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by MHK's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MHK insider trades
  • None no insider bought on the open market
  • $32.2M sold by 5 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Suzanne L Helen Insider
    Sale
    $100K 800 shares at $125.62 13% of stake
    Traded Sep 18 Filed Sep 18
    ↗
  2. Jeffrey S Lorberbaum CEO
    Sale
    $2.9M 22,875 shares at $128.59 5.7% of stake
    Traded Sep 15–16 Filed Sep 17
    ↗
  3. Jeffrey S Lorberbaum CEO
    Sale
    $8.7M 68,625 shares at $127.07 15% of stake
    Traded Sep 11–14 Filed Sep 15
    ↗
  4. Suzanne L Helen Insider
    Sale
    $139K 1,000 shares at $139.48 14% of stake
    Traded Aug 14 Filed Aug 18
    ↗
  5. Bernard Thiers Director
    Sale
    $1.8M 13,393 shares at $134.98 13% of stake
    Traded Aug 5 Filed Aug 6
    ↗
  6. Suzanne L Helen Insider
    Sale
    $921K 7,000 shares at $131.52 50% of stake
    Traded Aug 3 Filed Aug 5
    ↗
  7. Jeffrey S Lorberbaum CEO
    Sale
    $7.8M 59,078 shares at $131.59
    Traded Aug 3 Filed Aug 5
    ↗
  8. David Lee Repp Svp-cao & Corporate Controller
    Sale
    $29K 225 shares at $130.59 11% of stake
    Traded Aug 3 Filed Aug 4
    ↗
  9. Suzanne L Helen Insider
    Sale
    $2.4M 21,600 shares at $112.73 61% of stake
    Traded Jun 17–18 Filed Jun 18
    ↗
  10. Suzanne L Helen Insider
    Sale
    $638K 5,742 shares at $111.10 14% of stake
    Traded Jun 12–16 Filed Jun 16
    ↗
  11. Jeffrey S Lorberbaum CEO
    Sale
    $559K 5,000 shares at $111.87 20% of stake
    Traded Jun 12–15 Filed Jun 16
    ↗
  12. Suzanne L Helen Insider
    Sale
    $697K 6,575 shares at $106.03 14% of stake
    Traded Jun 9 Filed Jun 11
    ↗
  13. Suzanne L Helen Insider
    Sale
    $300K 2,844 shares at $105.65 5.6% of stake
    Traded Jun 3–4 Filed Jun 5
    ↗
  14. Jeffrey S Lorberbaum CEO
    Sale
    $528K 5,000 shares at $105.53 17% of stake
    Traded May 27 Filed May 28
    ↗
  15. Jeffrey S Lorberbaum CEO
    Sale
    $373K 3,600 shares at $103.67 11% of stake
    Traded Mar 18 Filed May 28
    ↗

Also filed in the last 12 months, not counted as buying or selling: 27 share withholdings for taxes, 26 stock grants, 8 other transactions, and 2 sales back to the company.

Congress

No member of Congress reported trading MHK in the last three years. 2 members listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
8-K 2.02,7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated about 20 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $11.14B $10.84B $10.79B
Gross profit $2.71B $2.69B $2.57B
Gross margin * 24.3% 24.8% 23.9%
Net income -$439.52M $517.7M $369.9M
Net margin * -3.9% 4.8% 3.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $5.6B $5.5B $5.97B
Total non-current assets * $7.96B $7.28B $7.72B
Total assets $13.56B $12.78B $13.69B
Total current liabilities $3.15B $2.67B $2.72B
Total non-current liabilities * $2.78B $2.55B $2.59B
Total equity $7.62B $7.55B $8.37B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.33B $1.13B $1.06B
Cash from investing -$970.34M -$454.4M -$441.9M
Cash from financing -$210.68M -$629.5M -$470M
Net change in cash $132.93M $24M $189.5M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.